Aastrom Biosciences Inc., of Ann Arbor, Mich., appointed Warren Chaunce Bogard to its board.

Adventrx Pharmaceuticals Inc., of San Diego, appointed Bengt Gustavsson chairman of its scientific advisory board.

Alloy Ventures, of Palo Alto, Calif., appointed Michael Hunkapiller general partner.

Altus Pharmaceuticals Inc., of Cambridge, Mass., appointed Martin Williams vice president and head of corporate development.

Amylin Pharmaceuticals Inc., of La Jolla, Calif., said its president and CEO, Ginger Graham, was elected to the California Healthcare Institute's board.

Angiotech Pharmaceuticals Inc., of Vancouver, British Columbia, appointed Gary Ingenito senior vice president, clinical development and regulatory affairs.

Avigen Inc., of Alameda, Calif., appointed Michael Coffee chief business officer.

BayBio, of South San Francisco, appointed Corey Goodman, Victoria Hale, Steve James, Joel Marcus, Phil Moody, Alan Mendelson, Kim Popovits and Dan Welch to its board, and Neil Campbell, Tim Garlick, Elliot Parks and Michael Schuppenhauer to its economic advisory board.

Benitec Ltd., of Sydney, Australia, appointed Alexander Cappello to its board, and confirmed Sara Cunningham as CEO.

BioCryst Pharmaceuticals Inc., of Birmingham, Ala., appointed Randall Riggs vice president, business development.

Biolex Inc., of Pittsboro, N.C., appointed Dale Sander chief financial officer and senior vice president, finance.

Ceregene Inc., of San Diego, promoted Raymond Bartus to senior vice president and chief operating officer.

Cornerstone BioPharma Inc., of Cary, N.C., appointed Philip Pesin to its board.

Endologix Inc., of Irvine, Calif., appointed Herbert Mertens vice president of sales and marketing.

Genaera Corp., of Plymouth Meeting, Pa., appointed Michael Gast executive vice president and chief medical officer.

HTG Inc., of Tucson, Ariz., appointed Daniel Von Hoff and Raymond Woosley to its scientific advisory board.

Kos Pharmaceuticals Inc., of Cranbury, N.J., appointed William Pruitt to its board and chairman of its audit committee.